deltatrials
Unknown OBSERVATIONAL NCT04570982

Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal (CPT-R-Nepal)

Compassionate Use of Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Prospective Observational Study (Amended Protocol)

Sponsor: Dr. Pradip Gyanwali,MD

Conditions COVID-19
Interventions Convalescent Plasma
Updated 6 times since 2020 Last updated: Sep 29, 2020 Started: Jul 30, 2020 Primary completion: Oct 30, 2020 Completion: Dec 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04570982, this observational or N/A phase trial focuses on COVID-19 and remains ongoing. Sponsored by Dr. Pradip Gyanwali,MD, it has been updated 6 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Oct 2022 · 21 months · monthly snapshotRecruiting~Oct 2022 – ~Jul 2024 · 21 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  4. Oct 2022 — Jul 2024 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  5. Jan 2021 — Oct 2022 [monthly]

    Recruiting

▶ Show 1 earlier version

  1. Oct 2020 — Jan 2021 [monthly]

    Recruiting

    First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dr. Pradip Gyanwali,MD
  • Ministry of Health and Population, Nepal
Data source: Nepal Health Research Council

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations